NF
TMO icon

Nvest Financial’s Thermo Fisher Scientific TMO Stock Holding History

Nvest Financial’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$386K Sell
785
-3
-0.4% -$1.63K 0.14% 106
2025
Q4 		$456K Buy
788
+14
+2% +$7.92K 0.19% 91
2025
Q3 		$375K Sell
774
-36
-4% -$16.8K 0.22% 88
2025
Q2 		$328K Buy
810
+63
+8% +$26.3K 0.17% 85
2025
Q1 		$372K Sell
747
-1,979
-73% -$1.07M 0.2% 73
2024
Q4 		$1.42M Sell
2,726
-39
-1% -$21.4K 0.72% 40
2024
Q3 		$1.71M Buy
2,765
+71
+3% +$42K 0.98% 34
2024
Q2 		$1.49M Buy
2,694
+183
+7% +$105K 0.92% 36
2024
Q1 		$1.46M Sell
2,511
-31
-1% -$17.4K 0.97% 32
2023
Q4 		$1.35M Buy
2,542
+95
+4% +$46K 1.06% 30
2023
Q3 		$1.24M Sell
2,447
-90
-4% -$48K 1.16% 28
2023
Q2 		$1.32M Buy
2,537
+164
+7% +$88.5K 1.16% 27
2023
Q1 		$1.37M Sell
2,373
-30
-1% -$16.9K 1.42% 23
2022
Q4 		$1.32M Buy
2,403
+167
+7% +$88.5K 1.66% 21
2022
Q3 		$1.13M Sell
2,236
-127
-5% -$71.1K 1.6% 25
2022
Q2 		$1.28M Sell
2,363
-380
-14% -$209K 1.35% 25
2022
Q1 		$1.62M Buy
+2,743
New +$1.58M 1.33% 23

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nvest Financial's TMO Position: Q1 2026 in Review

Nvest Financial reduced its Thermo Fisher Scientific (TMO) stake by 0.38% in Q1 2026, selling an estimated $1.63K and leaving 785 shares worth $386K. The position accounts for 0.14% of the portfolio, ranked #106.

Nvest Financial first reported a position in TMO in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.71M in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Nvest Financial held 785 shares of Thermo Fisher Scientific worth $386K as of Q1 2026.
  • Nvest Financial sold 3 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.63K.
  • Thermo Fisher Scientific made up 0.14% of Nvest Financial's portfolio in Q1 2026, its #106 holding.
  • Nvest Financial first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 17 quarters since.
  • Nvest Financial's Thermo Fisher Scientific position peaked at $1.71M in Q3 2024.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Nvest Financial's 13F filing for Q1 2026, filed 28 Apr 2026.